622 / 1726
Survival after relapse in PORTEC-1
PORTEC Post relapse survival - no RT arm
First failure LRMD
0
2
4
6
8
10
0
25
50
75
100
Vaginal
Pelvic
Meta
years
r 2004 - 10:13:55
Logrank P<.001
Vaginal
36 10
Pelvic
10 9
Meta
12 9
N F
PORTEC Post relapse survival
Treatment arm
Cumulative percentage
0
2
4
6
8
10
0
25
50
75
100
RT
no RT
years
29 Apr 2004 - 10:13:55
At risk:
RT 38
12
5
2
1
1
no RT 58
32
25
10
5
1
Logrank P<.001
RT
38 34
no RT 58 28
N F
By treatment arm
By site of relapse
➢
Vaginal brachytherapy?
Creutzberg et al, Gynecol Oncol 2003